{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:59:40Z","timestamp":1793746780136,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaoxing Municipal Project of Health Science, Technology Plan","award":["2020A13027"],"award-info":[{"award-number":["2020A13027"]}]},{"name":"Medicine and Health Science and Technology Plan Project in Zhejiang Province of China","award":["2022KY1321"],"award-info":[{"award-number":["2022KY1321"]}]},{"name":"Key Laboratory of Functional Molecular Imaging of Tumor and Interventional Diagnosis and Treatment of Shaoxing City","award":["2020ZDSYSO1"],"award-info":[{"award-number":["2020ZDSYSO1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02868-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:07:08Z","timestamp":1751375228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A T2 weighted imaging-based radiomics nomogram for the classification of hepatic blood-rich lesions: hepatocellular carcinoma and benign liver lesions"],"prefix":"10.1007","volume":"16","author":[{"given":"Chen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boburjon","family":"Turgunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fandong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-8677","authenticated-orcid":false,"given":"Zhenhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"2868_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2868_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"key":"2868_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.20517\/2394-5079.2020.42","volume":"6","author":"A Osho","year":"2020","unstructured":"Osho A, Rich NE, Singal AG. Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response. Hepatoma Res. 2020;6:55. https:\/\/doi.org\/10.20517\/2394-5079.2020.42.","journal-title":"Hepatoma Res"},{"issue":"10","key":"2868_CR4","doi-asserted-by":"publisher","first-page":"300060520943415","DOI":"10.1177\/0300060520943415","volume":"48","author":"SY Wang","year":"2020","unstructured":"Wang SY, Yin L, Wang C, Ma MP. Atypical magnetic resonance imaging features and differential diagnosis of hepatocellular carcinoma. J Int Med Res. 2020;48(10):300060520943415. https:\/\/doi.org\/10.1177\/0300060520943415.","journal-title":"J Int Med Res"},{"issue":"1","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00330-019-06369-4","volume":"30","author":"CJ Zech","year":"2020","unstructured":"Zech CJ, Ba-Ssalamah A, Berg T, et al. Consensus report from the 8th international forum for liver magnetic resonance imaging. Eur Radiol. 2020;30(1):370\u201382. https:\/\/doi.org\/10.1007\/s00330-019-06369-4.","journal-title":"Eur Radiol"},{"issue":"2","key":"2868_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2214\/AJR.17.19341","volume":"211","author":"A Kitao","year":"2018","unstructured":"Kitao A, Matsui O, Yoneda N, et al. Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of Gadoxetic Acid-Enhanced MRI and focal nodular hyperplasia by CT and MRI. AJR Am J Roentgenol. 2018;211(2):347\u201357. https:\/\/doi.org\/10.2214\/AJR.17.19341.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"2868_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.crad.2017.07.001","volume":"72","author":"RH Jones","year":"2017","unstructured":"Jones RH, Taylor AJ, Rostambeigi N, Spilseth B. Small hepatocellular carcinomas displayed as a ring enhancing mass on arterial phase MRI in the chronically diseased liver. Clin Radiol. 2017;72(11):995. https:\/\/doi.org\/10.1016\/j.crad.2017.07.001.","journal-title":"Clin Radiol."},{"issue":"11","key":"2868_CR8","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1007\/s00330-019-06210-y","volume":"29","author":"P Lebert","year":"2019","unstructured":"Lebert P, Adens-Fauquembergue M, Azahaf M, et al. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio. Eur Radiol. 2019;29(11):5742\u201351. https:\/\/doi.org\/10.1007\/s00330-019-06210-y.","journal-title":"Eur Radiol"},{"issue":"3","key":"2868_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s13244-015-0399-8","volume":"6","author":"M Khanna","year":"2015","unstructured":"Khanna M, Ramanathan S, Fasih N, et al. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6(3):347\u201362. https:\/\/doi.org\/10.1007\/s13244-015-0399-8.","journal-title":"Insights Imaging"},{"key":"2868_CR10","doi-asserted-by":"publisher","first-page":"564307","DOI":"10.3389\/fonc.2020.564307","volume":"10","author":"W Liang","year":"2020","unstructured":"Liang W, Shao J, Liu W, et al. Differentiating hepatic epithelioid Angiomyolipoma from hepatocellular carcinoma and focal nodular hyperplasia via radiomics models. Front Oncol. 2020;10:564307. https:\/\/doi.org\/10.3389\/fonc.2020.564307.","journal-title":"Front Oncol"},{"issue":"1","key":"2868_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/hep.29487","volume":"67","author":"LR Roberts","year":"2018","unstructured":"Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Hepatology. 2018;67(1):401\u201321. https:\/\/doi.org\/10.1002\/hep.29487.","journal-title":"Hepatology"},{"issue":"12","key":"2868_CR12","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1007\/s00330-019-06294-6","volume":"29","author":"J Li","year":"2019","unstructured":"Li J, Wang J, Lei L, et al. The diagnostic performance of Gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. Eur Radiol. 2019;29(12):6519\u201328. https:\/\/doi.org\/10.1007\/s00330-019-06294-6.","journal-title":"Eur Radiol"},{"issue":"7","key":"2868_CR13","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1002\/mp.12291","volume":"44","author":"I Gatos","year":"2017","unstructured":"Gatos I, Tsantis S, Karamesini M, et al. Focal liver lesions segmentation and classification in nonenhanced T2-weighted MRI. Med Phys. 2017;44(7):3695\u2013705. https:\/\/doi.org\/10.1002\/mp.12291.","journal-title":"Med Phys"},{"issue":"2","key":"2868_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/diagnostics11020323","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, Hu Y, Han J, et al. Clinical application of liver imaging reporting and data system for characterizing liver neoplasms: A Meta-Analysis. Diagnostics (Basel Switzerland). 2021;11(2):323. https:\/\/doi.org\/10.3390\/diagnostics11020323.","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"12","key":"2868_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the Bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2868_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00261-019-02378-5","volume":"46","author":"S Lewis","year":"2021","unstructured":"Lewis S, Hectors S, Taouli B. Radiomics of hepatocellular carcinoma. Abdom Radiol (NY). 2021;46(1):111\u201323. https:\/\/doi.org\/10.1007\/s00261-019-02378-5.","journal-title":"Abdom Radiol (NY)"},{"key":"2868_CR17","doi-asserted-by":"publisher","first-page":"744756","DOI":"10.3389\/fonc.2021.744756","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhou Y, Zhang Y, et al. Radiomics based on Contrast-Enhanced MRI in differentiation between Fat-Poor Angiomyolipoma and hepatocellular carcinoma in noncirrhotic liver: A multicenter analysis. Front Oncol. 2021;11:744756. https:\/\/doi.org\/10.3389\/fonc.2021.744756.","journal-title":"Front Oncol"},{"issue":"6","key":"2868_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.acra.2020.04.027","volume":"28","author":"P Nie","year":"2021","unstructured":"Nie P, Wang N, Pang J, et al. CT-Based radiomics nomogram: A potential tool for differentiating hepatocellular adenoma from hepatocellular carcinoma in the noncirrhotic liver. Acad Radiol. 2021;28(6):799\u2013807. https:\/\/doi.org\/10.1016\/j.acra.2020.04.027.","journal-title":"Acad Radiol"},{"issue":"1","key":"2868_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12880-017-0212-x","volume":"17","author":"Z Li","year":"2017","unstructured":"Li Z, Mao Y, Huang W, et al. Texture-based classification of different single liver lesion based on SPAIR T2W MRI images. BMC Med Imaging. 2017;17(1):42. https:\/\/doi.org\/10.1186\/s12880-017-0212-x.","journal-title":"BMC Med Imaging"},{"issue":"2","key":"2868_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3348\/kjr.2018.0339","volume":"20","author":"M Kim","year":"2019","unstructured":"Kim M, Kang TW, Cha DI, et al. Identification of arterial hyperenhancement in CT and MRI in patients with hepatocellular carcinoma: value of unenhanced images. Korean J Radiol. 2019;20(2):236\u201345. https:\/\/doi.org\/10.3348\/kjr.2018.0339.","journal-title":"Korean J Radiol"},{"issue":"12","key":"2868_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/lt.24867","volume":"23","author":"X Liu","year":"2017","unstructured":"Liu X, Jiang H, Chen J, et al. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis. Liver Transpl. 2017;23(12):1505\u201318. https:\/\/doi.org\/10.1002\/lt.24867.","journal-title":"Liver Transpl"},{"issue":"1","key":"2868_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00330-018-5559-z","volume":"29","author":"JS Song","year":"2019","unstructured":"Song JS, Choi EJ, Hwang SB, et al. LI-RADS v2014 categorization of hepatocellular carcinoma: intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and Gadoxetic acid-enhanced MRI. Eur Radiol. 2019;29(1):401\u201310. https:\/\/doi.org\/10.1007\/s00330-018-5559-z.","journal-title":"Eur Radiol"},{"issue":"4","key":"2868_CR23","doi-asserted-by":"publisher","first-page":"e0174944","DOI":"10.1371\/journal.pone.0174944","volume":"12","author":"SF Weng","year":"2017","unstructured":"Weng SF, Reps J, Kai J, et al. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS ONE. 2017;12(4):e0174944. https:\/\/doi.org\/10.1371\/journal.pone.0174944.","journal-title":"PLoS ONE"},{"issue":"1","key":"2868_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40644-020-00297-z","volume":"20","author":"P Nie","year":"2020","unstructured":"Nie P, Yang G, Guo J, et al. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver. Cancer Imaging. 2020;20(1):20. https:\/\/doi.org\/10.1186\/s40644-020-00297-z.","journal-title":"Cancer Imaging"},{"issue":"1","key":"2868_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12957-021-02266-7","volume":"19","author":"Z Ding","year":"2021","unstructured":"Ding Z, Lin K, Fu J, et al. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World J Surg Oncol. 2021;19(1):181. https:\/\/doi.org\/10.1186\/s12957-021-02266-7.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"2868_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40263-018-0500-1","volume":"32","author":"L Pasquini","year":"2018","unstructured":"Pasquini L, Napolitano A, Visconti E, et al. Gadolinium-Based contrast Agent-Related toxicities. CNS Drugs. 2018;32(3):229\u201340. https:\/\/doi.org\/10.1007\/s40263-018-0500-1.","journal-title":"CNS Drugs"},{"issue":"3","key":"2868_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nephro.2021.04.001","volume":"17","author":"\u00c9 Pillebout","year":"2021","unstructured":"Pillebout \u00c9, Martinez F. Toxicit\u00e9 R\u00e9nale des produits de contraste radiologiques [Contrast-induced acute kidney injury]. Nephrol Ther. 2021;17(3):191\u20138. https:\/\/doi.org\/10.1016\/j.nephro.2021.04.001.","journal-title":"Nephrol Ther"},{"issue":"1","key":"2868_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12880-019-0321-9","volume":"19","author":"J Wu","year":"2019","unstructured":"Wu J, Liu A, Cui J, Chen A, et al. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on Precontrast magnetic resonance images. BMC Med Imaging. 2019;19(1):23. https:\/\/doi.org\/10.1186\/s12880-019-0321-9.","journal-title":"BMC Med Imaging"},{"issue":"30","key":"2868_CR29","doi-asserted-by":"publisher","first-page":"10249","DOI":"10.3748\/wjg.v20.i30.10249","volume":"20","author":"LL Han","year":"2014","unstructured":"Han LL, Lv Y, Guo H, et al. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol. 2014;20(30):10249\u201361. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10249.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2868_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","volume":"26","author":"P Luo","year":"2020","unstructured":"Luo P, Wu S, Yu Y, et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol Oncol Res. 2020;26(2):599\u2013603. https:\/\/doi.org\/10.1007\/s12253-019-00585-5.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"2868_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jvh.13388","volume":"28","author":"X Qian","year":"2021","unstructured":"Qian X, Liu S, Long H, et al. Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy. J Viral Hepat. 2021;28(1):20\u20139. https:\/\/doi.org\/10.1111\/jvh.13388.","journal-title":"J Viral Hepat"},{"issue":"1","key":"2868_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2019.10.010","volume":"156","author":"BW Wormald","year":"2020","unstructured":"Wormald BW, Doran SJ, Ind TE, et al. Radiomic features of cervical cancer on T2-and diffusion-weighted MRI: prognostic value in low-volume tumors suitable for trachelectomy. Gynecol Oncol. 2020;156(1):107\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2019.10.010.","journal-title":"Gynecol Oncol"},{"issue":"1114","key":"2868_CR33","doi-asserted-by":"publisher","first-page":"20190762","DOI":"10.1259\/bjr.20190762","volume":"93","author":"X Hu","year":"2020","unstructured":"Hu X, Ye W, Li Z, et al. Non-invasive evaluation for benign and malignant subcentimeter pulmonary ground-glass nodules (\u2264\u20091\u00a0cm) based on CT texture analysis. Br J Radiol. 2020;93(1114):20190762. https:\/\/doi.org\/10.1259\/bjr.20190762.","journal-title":"Br J Radiol"},{"key":"2868_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.suronc.2018.11.013","volume":"28","author":"W Cai","year":"2019","unstructured":"Cai W, He B, Hu M, et al. A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma. Surg Oncol. 2019;28:78\u201385. https:\/\/doi.org\/10.1016\/j.suronc.2018.11.013.","journal-title":"Surg Oncol"},{"issue":"12","key":"2868_CR35","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/MNM.0000000000001469","volume":"42","author":"A Sharma","year":"2021","unstructured":"Sharma A, Kumar S, Pandey AK, et al. Haralick texture features extracted from Ga-68 PSMA PET\/CT to differentiate normal prostate from prostate cancer: a feasibility study. Nucl Med Commun. 2021;42(12):1347\u201354. https:\/\/doi.org\/10.1097\/MNM.0000000000001469.","journal-title":"Nucl Med Commun"},{"key":"2868_CR36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fonc.2020.00602","volume":"10","author":"M Yan","year":"2020","unstructured":"Yan M, Wang W. A Non-invasive method to diagnose lung adenocarcinoma. Front Oncol. 2020;10:602. https:\/\/doi.org\/10.3389\/fonc.2020.00602.","journal-title":"Front Oncol"},{"issue":"3","key":"2868_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jtho.2016.11.2226","volume":"12","author":"TP Coroller","year":"2017","unstructured":"Coroller TP, Agrawal V, Huynh E, et al. Radiomic-Based pathological response prediction from primary tumors and lymph nodes in NSCLC. J Thorac Oncol. 2017;12(3):467\u201376. https:\/\/doi.org\/10.1016\/j.jtho.2016.11.2226.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2868_CR38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/diagnostics12051085","volume":"12","author":"V Brancato","year":"2022","unstructured":"Brancato V, Garbino N, Salvatore M, Cavaliere C. MRI-Based radiomic features help identify lesions and predict histopathological grade of hepatocellular carcinoma. Diagnostics (Basel). 2022;12(5):1085. https:\/\/doi.org\/10.3390\/diagnostics12051085.","journal-title":"Diagnostics (Basel)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02868-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:52Z","timestamp":1751418352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02868-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02868-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Medical Research Ethics Committee and the Institutional Review Board of Shaoxing People\u2019s Hospital (No. 2021-K-Y-085-01) in accordance with the Declaration of Helsinki (as revised in 2013). Due to the retrospective nature of the study, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1223"}}